期刊文献+
共找到13篇文章
< 1 >
每页显示 20 50 100
Post-appendectomy pelvic abscess with extended-spectrum beta-lactamase producing Escherichia coli : A case report and review of literature 被引量:2
1
作者 Andrew Tse Rajkumar Cheluvappa Selwyn Selvendran 《World Journal of Clinical Cases》 SCIE 2018年第16期1175-1181,共7页
BACKGROUND Appendicitis, the inflammation of the appendix, is the most common abdominal surgical emergency requiring expedient surgical intervention. Extendedspectrum beta-lactamases(ESBLs) are bacterial enzymes that ... BACKGROUND Appendicitis, the inflammation of the appendix, is the most common abdominal surgical emergency requiring expedient surgical intervention. Extendedspectrum beta-lactamases(ESBLs) are bacterial enzymes that catalyse the degradation of the betalactam ring of penicillins and cephalosporins(but without carbapenemase activity), leading to resistance of these bacteria to beta-lactam antibiotics. Recent increases in incidence of ESBL-producing bacteria have caused alarm worldwide. Proportion estimates of ESBLEnterobacteriaceae hover around 46% in China, 42% in East Africa, 12% in Germany, and 8% in the United States.CASE SUMMARY The impact of ESBL-producing bacteria on appendiceal abscesses and consequent pelvic abscesses are yet to be examined in depth. A literature review using the search words "appendiceal abscesses" and "ESBL Escherichia coli(E. coli)" revealed very few cases involving ESBL E. coli in any capacity in the context of appendiceal abscesses. This report describes the clinical aspects of a patient with appendicitis whodeveloped a postoperative pelvic abscess infected with ESBL-producing E. coli. In this report, we discuss the risk factors for contracting ESBL E. coli infection in appendicitis and post-appendectomy pelvis abscesses. We also discuss our management approach for postappendectomy ESBL E. coli pelvic abscesses, including drainage, pathogen identification, and pathogen characterisation. When ESBL E. coli is confirmed, carbapenem antibiotics should be promptly administered, as was done efficaciously with this patient. Our report is the first one in a developed country involving ESBL E. coli related surgical complications in association with a routine laparoscopic appendectomy.CONCLUSION Our report is the first involving ESBL E. coli and appendiceal abscesses, and that too consequent to laparoscopic appendectomy. 展开更多
关键词 APPENDECTOMY APPENDICEAL ABSCESS Appendicitis beta-lactam Antibiotic resistance beta-lactamASE Carbanepem CEPHALOSPORIN Escherichia coli Extended-spectrum beta-lactamASE Infection Pelvic ABSCESS Penicillin Case report
下载PDF
Pathogenicity and Antimicrobial Resistance in Coagulase-Negative Staphylococci
2
作者 Debora Brito Goulart 《Journal of Biosciences and Medicines》 CAS 2023年第5期9-29,共21页
The coagulase-negative staphylococci (CoNS) group was considered saprophytic or rarely pathogenic for many years. Since the first case of septicemia caused by CoNS, there has been a progressive increase in the prevale... The coagulase-negative staphylococci (CoNS) group was considered saprophytic or rarely pathogenic for many years. Since the first case of septicemia caused by CoNS, there has been a progressive increase in the prevalence of healthcare-associated infections caused by CoNS. The CoNS group has emerged as one of the main causes of nosocomial infections related to vascular catheters and prostheses, especially among immunocompromised patients. This gradual increase in infections is due to the change in the relationship between patients and procedures since CoNS are closely related to devices implanted in the human body. CoNS are successful in colonizing the host because they have several virulence mechanisms, such as biofilm formation and production of enzymes and toxins, in addition to several mechanisms of resistance to antimicrobials. Despite their great clinical relevance, few studies have focused on CoNS’s pathogenicity and resistance to antimicrobials, which reveals the current need to better understand the factors by which this group became pathogenic to humans and other animals. This review aims to synthesize the aspects related to the pathogenicity and antimicrobial resistance in CoNS. 展开更多
关键词 Coagulase-Negative Staphylococci Antimicrobial-Resistance BIOFILM Nosocomial Infections PATHOGENESIS beta-lactams Antibiotics Glycopeptide Antibiotics Macrolide Antibiotics SEPTICEMIA BACTEREMIA
下载PDF
苏州地区儿童感染流感嗜血杆菌β内酰胺酶基因检测 被引量:12
3
作者 陶云珍 丁云芳 +3 位作者 张建华 糜祖煌 诸丽娟 闵兰芳 《中国抗感染化疗杂志》 2005年第2期108-110,共3页
目的 了解苏州地区儿童感染流感嗜血杆菌(Hi)对氨苄西林的耐药情况,并从分子生物学的角度研究其耐药机制。方法 对135株Hi临床分离株用K B法作药敏试验,头孢硝噻吩显色法进行β内酰胺酶测定,PCR法进行β内酰胺酶基因TEM、ROB测定。结... 目的 了解苏州地区儿童感染流感嗜血杆菌(Hi)对氨苄西林的耐药情况,并从分子生物学的角度研究其耐药机制。方法 对135株Hi临床分离株用K B法作药敏试验,头孢硝噻吩显色法进行β内酰胺酶测定,PCR法进行β内酰胺酶基因TEM、ROB测定。结果 本地区儿童感染Hi对氨苄西林的耐药率为17.8%,所有耐药株均产β内酰胺酶,未发现β内酰胺酶阴性耐氨苄西林Hi (BLNAR)菌株。β内酰胺酶基因TEM的检出率为27.4%(10.4%氨苄西林敏感株也检出TEM基因),ROB为0.7%(该ROB型株同时携带TEM 基因),发现1株非TEM非ROB 型产β内酰胺酶Hi。结论 本地区儿童感染Hi对氨苄西林的耐药情况不容乐观,其耐药机制主要是产生β内酰胺酶,且以TEM型为主,携带TEM基因的氨苄西林敏感株的出现,是否预示新一轮氨苄西林耐药株的产生,值得关注。 展开更多
关键词 流感嗜血杆菌 Β内酰胺酶 耐药基因 儿童
下载PDF
常见革兰阴性杆菌高活性β-内酰胺酶的检测 被引量:4
4
作者 刘金波 何海明 +1 位作者 王国宝 葛德元 《临床军医杂志》 CAS 2004年第3期90-92,共3页
目的 通过对常见革兰阴性杆菌进行ESBLs和高产AmpC酶的检测 ,了解其在临床的检出率 ,以指导临床用药。方法 用改良的酶提取物三维试验方法进行持续高产AmpC酶和ESBLs的检测 ,并用此法与双纸片扩散法进行比较。 结果 在常见革兰阴性... 目的 通过对常见革兰阴性杆菌进行ESBLs和高产AmpC酶的检测 ,了解其在临床的检出率 ,以指导临床用药。方法 用改良的酶提取物三维试验方法进行持续高产AmpC酶和ESBLs的检测 ,并用此法与双纸片扩散法进行比较。 结果 在常见革兰阴性杆菌中高产AmpC酶分别为阴沟肠杆菌 2 0 4%,鲍曼不动杆菌 16.7%,弗劳地枸橼酸杆菌 10 0 %,铜绿假单胞菌 8.6%,肺炎克雷伯菌 7 1%,大肠埃希菌4 4%;ESBLs的检出率分别为肺炎克雷伯菌 2 8 6%,大肠埃希菌 2 7 9%,阴沟肠杆菌 18 4%,鲍曼不动杆菌 13 3 %,铜绿假单胞菌 8 6%。对同时产两类酶的菌株双纸片扩散法检测ESBLs可出现假阴性。结论 对革兰阴性杆菌可使用改良的三维法同时进行ESBLs和高产Am pC酶的检测 ,双纸片扩散法检测ESBLs可应用于所有革兰阴性杆菌的检测 ,但应注意有假阴性 。 展开更多
关键词 革兰阴性杆菌 高活性β-内酰胺酶 改良三维实验 双纸片扩散法
下载PDF
值得期待的新β内酰胺酶抑制剂阿维巴坦及其复合制剂 被引量:12
5
作者 杨帆 王明华 《第三军医大学学报》 CAS CSCD 北大核心 2013年第23期2498-2501,共4页
β内酰胺类抗生素是临床最为常用的抗菌药物。近10年世界范围内分离的肠杆菌科细菌、非发酵革兰阴性菌由于产超广谱β内酰胺酶(ESBLs)、AmpC酶和碳青霉烯酶(KPC),对青霉素类、头孢菌素类、β内酰胺酶抑制剂复方制剂乃至碳青霉烯类... β内酰胺类抗生素是临床最为常用的抗菌药物。近10年世界范围内分离的肠杆菌科细菌、非发酵革兰阴性菌由于产超广谱β内酰胺酶(ESBLs)、AmpC酶和碳青霉烯酶(KPC),对青霉素类、头孢菌素类、β内酰胺酶抑制剂复方制剂乃至碳青霉烯类抗生素耐药现象严重。产KPC酶是目前肠杆菌科细菌对碳青霉烯类耐药的最主要原闪。产β内酰胺酶的细菌对如喹诺酮类、氨基糖苷类、多粘菌素、替加环素等其他类别抗菌药物亦町耐药,给治疗带来重大挑战[1-2]。 展开更多
关键词 阿维巴坦 Β内酰胺酶抑制剂 丝氨酸β内酰胺酶
下载PDF
Antimicrobial Resistance and β-Lactamase Production among Hospital Dumpsite Isolates
6
作者 Olivia Sochi Egbule 《Journal of Environmental Protection》 2016年第7期1057-1063,共7页
Metallo-β-Lactamases (MBLs) and Extended Spectrum β-Lactamses (ESBLs) have emerged world-wide as a significant source of β-lactam resistance. The emergence of MBLs and ESBLs encoded on plasmids among Gram-negative ... Metallo-β-Lactamases (MBLs) and Extended Spectrum β-Lactamses (ESBLs) have emerged world-wide as a significant source of β-lactam resistance. The emergence of MBLs and ESBLs encoded on plasmids among Gram-negative pathogens in hospital dumpsites was investigated. Soils of different government and private hospitals were collected and processed following standard bacteriological techniques. Antimicrobial susceptibility testing was carried out by the disk-diffusion technique using Ceftazidime (30 μg), Cefuroxime (30 μg), Cefotaxime (30 μg), Cefixime (5 μg), Trimethprim-sulfamethoxazole (25 μg), Gentamycin (100 μg) Amoxicillin-Clavunalate (30 μg), Ciprofloxacin (5 μg), Ofloxacin (5 μg), Nitrofurantoin (300 μg) and Imipenem (10 μg). The role of plasmids in resistance was evaluated by subjecting isolates to curing using Sodium Dodecyl Sulfate (SDS). ESBLs production by Double-Disk Synergy Test (DDST) was carried out. Isolates resistant to Imipenem were subjected to a confirmatory test using Modified Hodge’s test and to MBLs production by DDST. Eighty-two Gram-negative isolates comprising of 32 (39.02%) Escherichia coli, 20 (24.39%) Serratia marcescens, 14 (17.07%) Klebsiella pneumonia, 10 (12.28%) Proteus mirabilis and 6 (7.32%) Enterobacter aerogenes were obtained. Susceptibility results revealed a 100% resistance of all isolates to Ceftazidime, Cefuroxime, Cefixime, Amoxycillin-clavulanate and Cefotaxime. A total of 66 (80.48%) isolates harboured plasmids out of which 26 (31.71%) isolates were ESBL producers. MBLs production was observed in 8 (25.00%) E. coli, 2 (2.41%) Klebsiella pneumonia and 2 (2.41%) Proteus mirabilis isolates. All MBLs producing isolates were ESBLs producers. The finding of highly resistant isolates producing ESBLs and MBLs in a hospital environment is quite disturbing and should be addressed urgently. 展开更多
关键词 Metallo-Beta Lactamases (MBLs) Extended Spectrum beta-lactamses (ESBLs) Plasmids Antimicrobial Resistance
下载PDF
老年人下呼吸道感染细菌谱及抗生素耐药性监测 被引量:9
7
作者 肖观莲 陈佑明 +2 位作者 黄敬 曾景文 彭若宇 《中国现代医学杂志》 CAS CSCD 2004年第13期127-130,共4页
目的探讨老年人下呼吸道感染细菌谱及致病菌株对抗生素的耐药性。方法采用微量肉汤稀释法及双纸片法测定了154株致病菌对20种抗生素的敏感性,并进行耐甲氧西林葡萄球菌和产超广谱β-内酰胺酶(ESBLs)研究。结果革兰阳性菌34株,以凝固酶... 目的探讨老年人下呼吸道感染细菌谱及致病菌株对抗生素的耐药性。方法采用微量肉汤稀释法及双纸片法测定了154株致病菌对20种抗生素的敏感性,并进行耐甲氧西林葡萄球菌和产超广谱β-内酰胺酶(ESBLs)研究。结果革兰阳性菌34株,以凝固酶阴性葡萄球菌(50%)和金黄色葡萄球菌(26%)多见,万古霉素、利福平为最敏感。其中耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)检出率占59%,耐甲氧西林金黄色葡萄球菌(MRSA)为(67%),对青霉素、苯唑青霉素的耐药率,对万古霉素的敏感性均为100%。革兰阴性菌120株,克雷伯菌属(29%)和大肠埃希氏菌(18%)常见,亚胺硫霉素、阿米卡星、头孢他啶的抗菌活性最强,覆盖率广。17株产ESBLs主要为克雷伯菌(58%)和大肠埃希氏菌(29%)。结论老年人下呼吸道感染的常见致病菌中MRSA,MRCNS和产ESBLs的比例很高。开展细菌药物敏感性监测,以强调临床合理使用抗生素。 展开更多
关键词 老年人 下呼吸道感染 抗生素耐药性 超广谱Β-内酰胺酶
下载PDF
阴沟肠杆菌耐药性与AMEs及BLa基因研究 被引量:4
8
作者 植志全 江广添 +3 位作者 许海鸥 邹惠锋 江鹏 何志恒 《中国热带医学》 CAS 2007年第9期1511-1513,1519,共4页
目的了解分离的阴沟肠杆菌耐药性及氨基糖苷类修饰酶、β-内酰胺酶相关基因存在状况,给防治提供参考。方法采用MicroScan微生物鉴定系统Neg Combo Panel Type 21阴性复合板微量肉汤法测定临床分离的20株阴沟肠杆菌对抗菌药物的敏感性... 目的了解分离的阴沟肠杆菌耐药性及氨基糖苷类修饰酶、β-内酰胺酶相关基因存在状况,给防治提供参考。方法采用MicroScan微生物鉴定系统Neg Combo Panel Type 21阴性复合板微量肉汤法测定临床分离的20株阴沟肠杆菌对抗菌药物的敏感性,采用聚合酶链反应方法分析氨基糖苷类修饰酶及β-内酰胺酶编码基因。结果20株菌均呈严重多重耐药,仅对亚胺培南高度敏感(耐药率5.0%),哌拉西林/他唑巴坦耐药率50.0%,对包括3、4代头孢在内的其他β-内酰胺类及氨基糖苷类抗生素耐药率90.0%~100.0%,对复方新诺明耐药率100%;20株菌均检出氨基糖苷类修饰酶基因,未检出aac(3)-Ⅲ和aac(3)-Ⅳ基因;19株(95.0%)菌检出β-内酰胺酶相关基因,TEM和DHA基因阳性率均为70%,9株菌(45.0%)同时检出TEM和DHA基因,未检出SHV、OXA、PER、VEB和GES基因。结论广州地区医院感染阴沟肠杆菌多重耐药严重,氨基糖苷类修饰酶基因、DHA型质粒AmpC酶基因和TEM型β-内酰胺酶基因携带率高,在介导细菌耐药方面起重要作用。 展开更多
关键词 阴沟肠杆菌 耐药性 Β-内酰胺酶类 抗生素 氨基糖苷 基因
下载PDF
产ESBLs菌株的流行现状及耐药性分析 被引量:8
9
作者 李丹 《中国医药科学》 2012年第13期54-56,共3页
目的了解产ESBLs菌株的流行现状,依照新版CLSI文件指导原则对产ESBLs菌株的耐药性进行分析,为临床治疗产ESBLs菌株感染提供依据。方法收集笔者所在医院2010年8月~2011年12月临床标本中分离的大肠埃希菌和肺炎克雷伯菌,采用DL-96细菌测... 目的了解产ESBLs菌株的流行现状,依照新版CLSI文件指导原则对产ESBLs菌株的耐药性进行分析,为临床治疗产ESBLs菌株感染提供依据。方法收集笔者所在医院2010年8月~2011年12月临床标本中分离的大肠埃希菌和肺炎克雷伯菌,采用DL-96细菌测定系统进行检测分析。结果大肠埃希菌ESBLs检出率为64.8%,肺炎克雷伯菌ESBLs检出率为31.6%;在药敏方面,依照新版CLSI文件指导原则,产ESBLs菌株对头孢他啶、头孢吡肟、氨曲南的敏感结果不再报为耐药;产ESBLs菌株对碳青霉烯类仍具有极高的敏感率;对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦、头孢西丁、阿米卡星、美满霉素的敏感性较好;对氟喹诺酮类、阿莫西林/克拉维酸、氨苄西林/舒巴坦、磺胺甲恶唑/甲氧苄啶、庆大霉素、四环素的敏感性差。结论抗菌药物的不合理应用,使产ESBLs菌株大量出现,而新版CLSI文件指导原则为临床治疗产ESBLs菌株感染,使用敏感的头孢菌素和氨曲南提供了依据,临床上应提高感染性疾病标本的送检率,依据药敏结果,科学合理使用抗生素。 展开更多
关键词 CLSI 超广谱Β-内酰胺酶 大肠埃希菌 肺炎克雷伯菌
下载PDF
Probabilistic Antibiotic Therapy in the Infectious Diseases Department of the Yalgado Ouédraogo University Hospital (CHU-YO) in Ouagadougou, Burkina Faso
10
作者 Savadogo Mamoudou Bonané Faïz 《Advances in Infectious Diseases》 CAS 2022年第4期639-645,共7页
Introduction: In Burkina Faso, as in most developing countries, limited access to biological tests forces practitioners to resort very often to probabilistic antibiotic therapy. The objective of this study is to deter... Introduction: In Burkina Faso, as in most developing countries, limited access to biological tests forces practitioners to resort very often to probabilistic antibiotic therapy. The objective of this study is to determine the extent of this prescription. Patients and Methods: This was a cross-sectional study with retrospective data collection of patients hospitalized in the infectious diseases department in the period from January 1, 2005 to December 31, 2020. The records of patients who received probabilistic antibiotic therapy were included. Results: During the study period, 330 patients had received probabilistic antibiotic therapy. The majority of patients were male (53%), with a sex ratio of 1.12. The mean age of the patients was 33 years ± 14. The age range of 20 to 40 years was the most represented (42%). Fifteen percent (15%) of patients were living with HIV. The majority of patients were from urban areas (56.4%). Forty-nine percent (49%) of the patients worked in the informal sector. Clinically, the reasons for consultation were dominated by fever, alteration of general condition, neurological disorders, digestive disorders, respiratory signs, urinary signs and diffuse pain. The physical examination showed that 48.1% of the patients had meningeal irritation syndrome, 10% had convulsions and 10% had focal signs, trismus was present in 4% of the patients and facial paralysis in 3%. In the digestive system, hepatomegaly was present in 29% of patients and digestive candidiasis in 31%. Respiratory examination showed crepitus and fluid effusion syndrome in 26.83% and 20.62% of patients respectively. The presumptive diagnosis was dominated by bacterial meningitis, salmonellosis and bronchopneumonia with banal germs. In terms of treatment, the beta-lactam family of drugs was the most prescribed. They were followed by aminoglycosides and fluoroquinolones. The evolution was marked by the death of 50 patients (15%). Conclusion: The most prescribed molecules belong to the family of Beta-lactam. And this prescription improved the outcome of patients. Bacterial susceptibility studies will allow better orientation of probabilistic antibiotic therapy in order to limit the emergence of multi-resistant bacteria. 展开更多
关键词 Probabilistic Antibiotic Therapy beta-lactam Infectious Diseases Department of the Yalgado Ouédraogo University Hospital
下载PDF
多重耐药大肠杆菌耐药基因与整合子遗传标记基因间的相关性 被引量:7
11
作者 韩冬青 黄俊伟 +3 位作者 尚忠波 徐荣 楼永良 陈秀枢 《微生物学报》 CAS CSCD 北大核心 2011年第4期458-467,共10页
【目的】对多重耐药大肠埃希菌(Escherichia coli)临床株的β-内酰胺酶类(β-lactamases,BLs)和氨基糖苷钝化酶类(aminoglycoside modifying enzymes,AMEs)耐药基因与Ⅰ-Ⅲ类整合子遗传标记基因之间的相关性进行研究。【方法】采用VITEK... 【目的】对多重耐药大肠埃希菌(Escherichia coli)临床株的β-内酰胺酶类(β-lactamases,BLs)和氨基糖苷钝化酶类(aminoglycoside modifying enzymes,AMEs)耐药基因与Ⅰ-Ⅲ类整合子遗传标记基因之间的相关性进行研究。【方法】采用VITEK-GNS药敏卡测定136株E.coli对14种抗菌素的敏感性;纸片扩散法确认超广谱β-内酰胺酶(extended-spectrum beta-lactamases,ESBLs)产酶株;PCR法检测BLs、AMEs相关耐药基因及Ⅰ-Ⅲ类整合子遗传标记基因;接合传递试验和质粒提取对16S rRNA甲基化酶基因进行初步定位。【结果】136株多重耐药的E.coli ESBLs产生率高达70.59%(96/136),产酶株对氨苄西林、庆大霉素、妥布霉素、亚胺培南和哌拉西林/他唑巴坦以外的其余9种抗菌素的耐药率显著高于非产酶株(P<0.05)。BLs耐药基因总检出率为96.32%(131/136),1株外膜通道蛋白oprD2基因缺失,AMEs耐药基因总检出率为100%(136/136),Ⅰ类整合子遗传标记基因qacEΔ1-sul1的检出率为94.12%(128/136),未检出Ⅱ类与Ⅲ类整合子基因。BLs基因和AMEs基因与qacEΔ1-sul1遗传标记基因的同时携带率分别为90.44%(123/136)和94.12%(128/136),两类同时携带率之间的差异不具统计学意义(P>0.05),上述两类耐药基因与qacEΔ1-sul1遗传标记基因的三者同时携带率为90.44%(123/136)。此外,还检出16S rRNA甲基化酶基因12株(8.82%),其中,armA与rmtB的检出率分别为2.21%和7.35%,未检出rmtA、rmtC和rmtD。接合试验与质粒图谱结果初步表明:armA和rmtB编码基因位于约23 kb的质粒上,其耐药质粒在同种菌间的传递率高达83.3%(10/12)。【结论】多重耐药E.coli临床株的BLs基因、AMEs基因与qacEΔ1-sul1遗传标记基因三者同时携带率高达90.44%,表明多重耐药的形成在三者间具有密切的相关性;实验结果还显示:E.coli临床株的多重耐药性形成和传播与Ⅱ和Ⅲ类整合子基因无关。另外,16S rRNA甲基化酶基因携带率为8.82%(armA 2.21%和rmtB 7.35%),并初步证明armA和rmtB编码基因位于约23 kb的质粒上,其耐药质粒在同种菌间的传递率高达83.3%(10/12)。 展开更多
关键词 大肠埃希菌 多重耐药 Β-内酰胺酶 氨基糖苷钝化酶 整合子
原文传递
舒巴坦对产β-内酰胺酶菌株的抑酶增效作用 被引量:34
12
作者 胡云建 陈玉兰 胡继红 《中华检验医学杂志》 CAS CSCD 2000年第1期29-31,共3页
目的 比较哌拉西林、哌拉西林 /舒巴坦和氨苄西林 /舒巴坦对产 β 内酰胺酶细菌的抑酶增效作用。方法 以生物法测定 3 3株临床分离的革兰阴性杆菌和 5株标准菌株产 β 内酰胺酶对抗生素的相对水解率 ,抑酶保护率。结果 β 内酰胺酶... 目的 比较哌拉西林、哌拉西林 /舒巴坦和氨苄西林 /舒巴坦对产 β 内酰胺酶细菌的抑酶增效作用。方法 以生物法测定 3 3株临床分离的革兰阴性杆菌和 5株标准菌株产 β 内酰胺酶对抗生素的相对水解率 ,抑酶保护率。结果 β 内酰胺酶对哌拉西林 /舒巴坦各配比的相对水解率明显低于单独使用哌拉西林 (P <0 .0 1) ,结果还表明哌拉西林 /舒巴坦 ( 2∶1)与氨苄西林 /舒巴坦相同 (P >0 .0 5 )。哌拉西林 /舒巴坦不同配比间 ,随舒巴坦比例增大相对水解率降低 ,抑酶保护率提高 ,1∶1与 2∶1配比间无统计学意义 ,用中位数做显著性测试 ,1∶1与 4∶1配比间差异有显著性 ,P <0 .0 1。结论舒巴坦与哌拉西林合用提高了哌拉西林对产 β 内酰胺酶细菌的抗菌活性 ,预示将会有更好的临床疗效和应用前景。 展开更多
关键词 抗生素 Β-内酰胺酶 革兰氏阴性杆菌
原文传递
多重耐药绿脓假单胞菌β内酰胺类氨基糖苷类耐药相关基因研究 被引量:57
13
作者 植志全 何志恒 +4 位作者 江鹏 马劲光 江广添 许海鸥 邹惠锋 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第11期1211-1214,共4页
目的明确广州地区临床分离的耐药绿脓假单胞菌各种β内酰胺酶编码基因、外膜通道蛋白oprD2基因、氨基糖苷类修饰酶基因存在状况。方法采用MicroScan微生物鉴定系统微量肉汤法测定临床分离的18株绿脓假单胞菌对12种抗菌药物的敏感性,采... 目的明确广州地区临床分离的耐药绿脓假单胞菌各种β内酰胺酶编码基因、外膜通道蛋白oprD2基因、氨基糖苷类修饰酶基因存在状况。方法采用MicroScan微生物鉴定系统微量肉汤法测定临床分离的18株绿脓假单胞菌对12种抗菌药物的敏感性,采用聚合酶链反应及序列分析的方法分析β内酰胺酶基因型、氨基糖苷类修饰酶基因型及外膜通道蛋白oprD2基因。结果该18株菌呈现多重耐药,对氨基糖苷类抗生素的耐药率在50.0%~72.2%之间,对其他抗绿脓假单胞菌药物耐药率在16.7%~83.3%之间;14株(77.8%)检出氨基糖苷类修饰酶基因,aac(6')Ⅱ、aac(3)Ⅱ、ant(3")Ⅰ、aac(6')Ⅰ、ant(2")Ⅰ、aac(3)Ⅰ、aac(3)Ⅲ、aph(3')Ⅵ和aac(3)Ⅳ基因的阳性率分别为50.0%、38.9%、38.9%、33.3%、27.8%、11.1%、5.6%、5.6%和0;13株(72.2%)检出β内酰胺酶编码基因,TEM、DHA、IMP和OXA基因阳性率分别为55.6%、27.8%、22.2%和11.1%,SHV、PER、VER、GES和VIM基因阴性,3株外膜通道蛋白oprD2基因缺失。结论广州地区临床分离的绿脓假单胞菌多重耐药严重,氨基糖苷类修饰酶基因和β内酰胺酶编码基因携带率很高。 展开更多
关键词 假单胞菌 铜绿 抗药性 多重耐药 Β内酰胺酶类 抗生素类 氨基糖苷 基因
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部